Abstract | Thyroid hormone signalling regulates crucial biological functions, including energy expenditure, thermogenesis, development and growth. The skeletal muscle is a major target of thyroid hormone signalling. The type 2 and 3 iodothyronine deiodinases (DIO2 and DIO3, respectively) have been identified in skeletal muscle. DIO2 expression is tightly regulated and catalyses outer-ring monodeiodination of the secreted prohormone tetraiodothyronine (T 4 ) to generate the active hormone tri-iodothyronine (T 3 ). T 3 can remain in the myocyte to signal through nuclear receptors or exit the cell to mix with the extracellular pool. By contrast, DIO3 inactivates T 3 through removal of an inner-ring iodine. Regulation of the expression and activity of deiodinases constitutes a cell-autonomous, pre-receptor mechanism for controlling the intracellular concentration of T 3 . This local control of T 3 activity is crucial during the various phases of myogenesis. Here, we review the roles of T 3 in skeletal muscle development and homeostasis, with a focus on the emerging local deiodinase-mediated control of T 3 signalling. Moreover, we discuss these novel findings in the context of both muscle homeostasis and pathology, and examine how skeletal muscle deiodinase activity might be therapeutically harnessed to improve satellite-cell-mediated muscle repair in patients with skeletal muscle disorders, muscle atrophy or injury.
Introduction
Skeletal muscle is a principal target of thyroid hormone signalling, as exemplified by the myopathic symptoms that are observed in many patients with disorders of thy roid function. Whereas the underlying causes of muscle weakness, which is seen in both patients with hypo thyroidism and in those with thyrotoxicosis, are diverse and not completely understood, a clearer picture has emerged concerning the effects of thyroid hormones on muscle contractility and metabolism. 1 Skeletal muscle is characterized by a considerable degree of plasticity, allowing adaptation to changes in use and other external cues. 2 The interplay between the various intrinsic and extrinsic factors that drive muscle gene expression gives rise to four major muscle fibre types: type I, type IIa, type IIx and type IIb, here listed in order of increasing speed of contraction and overall ATPgenerating capacity. Type I muscle fibres are charac terized by expression of myosin7 (also known as myosin heavy chain 1), whereas type IIa fibres express myosin2 (also known as myosin heavy chain 2a), type IIx fibres express myosin1 (also known as myosin heavy chain 2x) and type IIb fibres express myosin4 (also known as myosin heavy chain 2b). In addition to these isoforms of myosin heavy chain, a range of fibretypespecific isoforms of other muscle proteins determine the pheno type of each fibre type. Notably, the SERCA2a isoform of the sarcoplasmicendoplasmic reticulum Ca
2+
ATPase is expressed at low levels in type I and type IIa muscle fibres, whereas SERCA1a is highly expressed in type IIx and type IIb muscle fibres. 1, 2 Increased SERCA1a expres sion in type IIx and type IIb muscle fibres is associated with a more extensive development of the sarco plasmic reticulum (SR) and a concomitant increase in the mobiliz able amount of SRstored Ca 2+ that is reversibly bound to calsequestrin 1, a lowaffinity, highcapacity Ca 2+ binding protein. 3, 4 The speed of muscle contraction and muscle relaxa tion, as well as the energy consumption associated with contractile activity is lowest in type I fibres, intermediate in type IIa and IIx fibres, and highest in type IIb fibres. The higher energy cost associated with the increase in speed is in part related to the abovementioned fibre typespecific gene expression. In particular, the levels of SERCA isoform expression determine the extent of Ca 2+ release and ATPconsuming reuptake by the SR during the contraction-relaxation cycle in every fibre type. Along with the greater reliance on glycolytic ATP pro duction, the higher contraction and relaxation speed in type II muscle fibres is associated with a greater degree of heat dissipation. 1 Mammalian skeletal muscles are com posed of varying combinations of slow and fast fibre types, and the graded recruitment of these fibres through their innervating motor neurons enables muscle activi ties ranging from short bursts of fast contraction to slow sustained contraction.
Thyroid hormonedependent gene expression is known to involve a wide array of genes in skeletal muscle. The concerted effects of thyroid hormone signal ling on both contractile and metabolic properties of muscle initially suggested a uniform mechanism of action in this tissue. However, studies thus far have indicated that the effects of thyroid hormone signalling in muscle development and function are the result of an exceptionally complex inter play of direct and indirect mechanisms. Adding to this complexity is the discovery of the regulated expression of type 2 iodothyronine deiodinase (DIO2) and type 3 iodothyronine deiodinase (DIO3), which generate and inactivate T 3 , respectively, in many tissues, including skel etal muscle. [5] [6] [7] [8] [9] Regulation of the expression and activity of DIO2 and DIO3 allows for a tissuespecific mode of modulation of intracellular thyroid hormone activity that is independent of the circulating thyroid hormone levels, thereby increasing the regulatory potential of thyroid hor mones in muscle gene expression. Here, we review studies that indicate the relevance of deiodinasemediated regu lation of thyroid hormone action for control of muscle development and regeneration, and discuss the therapeu tic implications of these findings. For a broader perspec tive on muscle satellite cell function and muscle repair, the reader is referred to more extensive reviews. [10] [11] [12] Thyroid hormone activation in skeletal muscle Normal muscle development, homeostasis and regenera tion require the binding of T 3 to the thyroid hormone nuclear receptors. 13, 14 The thyroid hormone trans porters MCT8 and MCT10, as well as the thyroid hormone con verting enzymes DIO2 and DIO3, are expressed in skel etal muscle of both humans and rodents. [7] [8] [9] [15] [16] [17] These proteins provide the potential for local control of the uptake of T 4 and T 3 , as well as of their activation and inactivation within the skeletal muscle tissue.
As in other DIO2expressing tissues, DIO2generated T 3 contributes substantially to the intracellular T 3 pool of the skeletal muscle. This finding is clearly demonstrated by kinetic studies in mice in which the intracellular levels of T 3 that is converted from T 4 by DIO2 were compared with those of T 3 that was obtained from the circula tion. 18 The ratio of DIO2derived to plasmaderived T 3 was found to be twofold to threefold higher in skeletal muscle than in the liver or kidney. 18 This ratio is even higher in hypothyroid mice, in which the expression Key points ■ Thyroid hormone signalling is required for skeletal muscle development, contractile function and muscle regeneration ■ As skeletal muscle comprises 30-40% of body mass, the altered basal metabolic rate in patients with thyroid hormone excess or deficiency is largely due to changes in skeletal muscle energy turnover ■ Functional studies indicate that the active thyroid hormone isoform T 3 signals predominantly through the thyroid-hormone receptor α1 (THRA1) isoform in skeletal muscle ■ Expression of the type 2 iodothyronine deiodinase (DIO2), which converts the prohormone T 4 to the active thyroid hormone isoform T 3 , is increased in developing or injured muscles ■ In the absence of DIO2, the muscle-specific thyroid hormone-dependent gene expression programme fails to be induced in the stem-cell-like satellite cells of skeletal muscle, resulting in impaired muscle regeneration ■ Current studies suggest that the dynamic control of thyroid hormone activity through the regulation of deiodinase expression can be harnessed to optimize myogenesis in patients with muscle diseases or injury of DIO2 is elevated in skeletal muscle. By contrast, this ratio was markedly reduced in the muscle of mice lacking Dio2 (Dio2
). 18 During differentiation of primary myo blast cultures from neonatal mice, Dio2 mRNA levels and DIO2 activity were both found to increase rapidly, leading to an increased ratio of intracellularly converted to extracellularly derived T 3 . 18, 19 This finding indicates an important physiological role for the elevated DIO2 expression in neonatal skeletal muscle development in mice, as also discussed below. 18, 19 Several studies have clearly demonstrated the con version of labelled T 4 to T 3 in cultured human skel etal myocytes. [20] [21] [22] The enzymatic activity of human DIO2, as measured in mixed fibretype skeletal muscle homo genates, is comparable with the enzymatic activ ity of mouse DIO2. 17, 23, 24 Nonetheless, studies on the regulation of DIO2 in human muscle have provided some un expected results. In contrast to rodents, hypo thyroidism does not increase DIO2 mRNA levels or DIO2 activity in humans. 24 As low T 4 levels promote DIO2 activ ity through posttranslational modifications, the absence of changes in DIO2 mRNA levels is not surprising. 25 How ever, the absence of an increase in DIO2 activity is puzzling and could perhaps be attributed to technical limitations, given the extremely low DIO2 activity in this tissue. Indeed, other studies identified a twofold to three fold increase in both DIO2 mRNA levels and DIO2 activ ity in skeletal muscle of chronically ill patients that had low serum T 4 levels. 23 Moreover, DIO2 mRNA levels were found to decrease with fasting and increase with insulin infusion, in agreement with rodent studies. [26] [27] [28] In contrast to DIO2, no changes were noted in DIO3 activity in skeletal muscle of patients with any of the above mentioned perturbations, although DIO3 activity and intracellular T 3 concentration have been reported to increase and decrease, respectively, in skeletal muscle of patients during hospitalization in an intensive care unit. 29 Thus, T 3 might decrease in a DIO3dependent manner in skeletal muscle of individuals with severe health prob lems, but more work is required to determine the cel lular compartment in muscle in which T 3 is inactivated by DIO3.
Interestingly, an increase in MCT8, but not MCT10, mRNA levels occurs in skeletal muscle of chronically severely ill patients dying of complications in a post surgical intensive care unit. 15 This phenomenon has been hypothesized to be a compensatory change in response to the patients' low T 3 levels. Apart from this observa tion, little is known about changes in skeletal muscle ex pression of thyroid hormone transporters.
T 3 -dependent muscle gene expression
The principal mode of action of thyroid hormones is through T 3 dependent nuclearreceptormediated stimu lation or inhibition of gene transcription. 14, 30 In muscle, this activity is primarily mediated by the THRA1 isoform of the thyroidhormone receptor. Thyroidhormone receptors bind in the unliganded state to thyroid hormoneresponsive elements in target genes, usually forming heterodimers with the ubiquitously expressed retinoic acid receptor RXR. The subsequent formation of a protein complex including the co repressor NCoR2 and histonemodifying enzymes leads to active repres sion of target gene transcription. 14, 30 When T 3 binds to the thyroidhormone receptor, repression is lifted, and tran scription is stimulated by the recruitment of coactivators to the complex.
Among proteins whose expression is transcriptionally regulated by T 3 in muscle are SERCA1a, 31 SERCA2a, 32 uncoupling protein 3 (UCP3), 33 GLUT4 (also known as SLC2A4), 34 which is the main glucose transporter in muscle, NADPdependent malic enzyme (ME1), 35 which catalyses the NADPHdependent decarboxylation of lactate, muscle glycerol3phosphate dehydrogenase (mGPDH), 36 which is highly expressed in mitochondria of fast muscle fibres, and myosin7.
37 MYH7, the gene encoding myosin7, is the only gene in this list that is transcriptionally repressed by T 3 . The regulation of the abovementioned proteins by thyroid hormone signal ling is congruent with the thyroidhormoneinduced shift to faster contractile function (that is, conver sion from type I to type II fibres) and the concomitant increase in both glycolytic and oxidative capacities.
In addition, several gene targets are thought to account for the wide range of concerted effects of thyroid hor mones in muscle development, homeostasis and regen eration. First, the transcription of two members of the myogenic regulatory factor (MRF) family, myogenin and myoblast determination protein 1 (MYOD1), is also induced by T 3 .
38,39 Apart from their role in myo blast differentiation, these MRFs can act as downstream transducers of thyroid hormone signalling in muscle. Thyroidhormonedependent expression of MYOD1 has indeed been shown to drive part of the fast muscle fibre phenotype, including transcriptional stimulation of the myosin1, myosin2 and myosin4 isoforms. [40] [41] [42] [43] In addition, T 3 reduces the expression and activity of the signalling protein calcineurin and its downstream tran scription factors, which are involved in maintenance of the slow phenotype of muscle fibres. 1 Finally, the overall effect of thyroid hormones on mitochondrial capacity is related to the T 3 mediated transcription of the gene encoding peroxisome proliferatoractivated receptor γ coactivator 1α (PGC1α), an important regulator of mitochondrial biogenesis. 2, 44, 45 This effect is supported by the transcriptional stimulation of mitochondrially encoded genes through a specific thyroidhormone receptor isoform (p43) present in mitochondria. 46 Thus, it becomes evident that thyroid hormone signal ling regulates the expression of a broad range of genes with central roles in skeletal muscle homeo stasis, func tion and metabolism. The effects of thyroidhormone dependent transcription in skeletal muscle development, plasticity and repair, as well as in energy expenditure and glucose homeostasis are discussed in detail below.
T 3 and skeletal muscle phenotype T 3 -dependent muscle development Early embryonic development of skeletal muscles of the trunk and limbs entails the commitment of cells of the dermomyotome to the myogenic lineage. This step is triggered by the transcription factor paired box protein PAX3 and consolidated by the expression of PAX7. 2 The PAX proteins activate several MRFs, which, in turn, induce musclespecific gene programmes to establish the myoblast lineages. This process is stimulated by thyroid hormone, by virtue of the T 3 responsiveness of several MRFs, as mentioned in the previous section. 47 Fusion of myoblasts results in formation of the pri mary, multi nucleated muscle fibres. Larger numbers of secon dary fibres form over the course of fetal development, drawing on the pool of continually proliferating myoblasts.
Postnatal muscle development and growth in rodents entails both de novo formation of fibres and muscle hypertrophy, which mainly involves the fusion of addi tional myoblasts to existing fibres. Hypertrophy is the predominant process of muscle growth in mice and requires accretion of myoblasts during the first 3 weeks following birth. 48 At this stage, the myoblasts are formed from resident satellite cells, the myogenic precursors present in skeletal muscle which are responsible for both fibre growth and muscle regeneration. 12 The role of thyroid hormone signalling in satellite cell function, muscle growth and muscle repair is discussed below.
Postnatal muscle growth coincides with the transi tion from fetal to various adult fibre phenotypes, and this process depends on both thyroid hormone signal ling and maturation of the motor nerve that innervates each individual fibre. 2 The levels of thyroid hormones in plasma increase immediately after birth in rodents, and the capacity of skeletal muscle to increase the intra cellular concentrations of T 3 via the activity of DIO2 is also high during this period (see also below). 19 The importance of thyroid hormone signalling for the switch in muscle fibre phenotypes in neonates is illustrated by the fact that in the absence of thyroid hormones, the switch from expression of the embryonic and neonatal isoforms of myosin heavy chain to expression of the adult myosin isoforms is delayed or incomplete, 2 whereas the expression of SERCA1a, which is essential for fast muscle relaxation, fails to increase.
T 3 -dependent muscle plasticity
The delayed contraction and relaxation of the deep tendon reflex is a classic observation in individuals with hypo thyroidism, whereas the opposite changes are observed in patients with thyrotoxicosis. 49 These clinical findings illustrate the integrated effect of thyroid hor mones on various properties of the skeletal muscle, including the co ntraction-relaxation cycle. The contribution of thyroid hormones to the plasticity of muscle phenotype is particu larly evident in the case of fibres that are innervated by slow motor neurons. Unlike fast fibres, development and maintenance of a slow contractility phenotype is depend ent on the almost continuous, low frequency stimulation pattern typical of slow motor innervation. 2 The effect of this stimulation is countered by thyroid hormone signal ling, which not only drives expression of genes that are involved in fast contractility, as mentioned in the previ ous section, but also stimulates mitochondrial activity and, particularly, glycolysis.
1 As a result, fibres that are innervated by slow motor neurons can develop a type I, type IIa, type IIx or type IIb pheno type to varying degrees, depending on the relative strength of these opposing forces. The modulation of contractile and metabolic proper ties of skeletal muscle in response to changes in thyroid hormone availability exemplifies the phenotypic flexi bility of skeletal muscle and indicates that thyroid hormones are in a dynamic balance with other exter nal cues to drive muscle gene expression. This balance helps to explain the changes in muscle properties that ch aracterize hypothyroidism and thyrotoxicosis (Table 1) .
Energy turnover and glucose metabolism
The impact of thyroid hormone availability on the speed of the contraction-relaxation cycle underlies the higher resting energy turnover and lower energetic efficiency of contraction in skeletal muscle in thyro toxicosis as com pared to hypothyroidism. 1 The thyroidhormone depend ent increase in ATP consumption, particularly during activity, is accommodated by quantitative and qualita tive changes in the ATPgenerating capacity of skeletal muscle. As skeletal muscle comprises 30-40% of body mass in humans, it is this tissue that primarily accounts for the wellknown effects of thyroid status on the meta bolic rate of the organism, both at rest and during activ ity. In addition to energy expenditure, thyroid hormone signalling can influence glucose uptake by skeletal muscle and, thereby, glucose homeostasis. ATPases, respectively, or decreasing the efficiency of ATP syn thesis via proton leak through mitochondrial UCP3, have all been proposed as mechanisms through which energy is 'wasted' and dissipated as heat in skeletal muscles. 50, 51 As mentioned above, it is wellestablished that thyroid hormone signalling promotes a shift from slow type I fibre phenotype to faster type II fibres, with the associ ated increase in myosin and SERCA expression leading to greater energy turnover and concomitant generation of heat during activity. 1 
52, 53 The relative contribution of these newly identified thyroid hormone gene targets to changes in muscle energy expenditure is still being defined.
In small mammals and human neonates, the UCP3 homologue UCP1 promotes mitochondrial uncou pling in brown adipose tissue (BAT). This wellknown T 3 dependent mechanism of energy expenditure, used to generate heat during the adaptive process of facul tative thermogenesis, is necessary for survival during cold expo sure. 51, 52 Individuals that had been treated with lio thyronine or levothyroxine, as well as patients with thyro toxicosis or with generalized resistance to thy roid hor mones that had elevated thyroid hormone serum levels, all exhibit increased mitochondrial uncou pling in muscle, which indicates that mitochondrial uncoupling is an impor tant source of energy expendi ture in this tissue. [54] [55] [56] UCP1 is not found in muscle, but UCP3 is expressed in this tissue in a T 3 dependent manner.
33, 50, 52, 53, 57 Although the precise contribution of UCP3 to energy expenditure has yet to be established, increased UCP3 expression in T 3 treated rats and levothyroxinetreated individuals has been correlated with increased resting metabolic rate and mitochon drial uncoupling in the muscles. 50, 56 Moreover, UCP3 expression has been shown to be increased in the skel etal muscle of a mouse model of alternative facultative thermogenesis owing to BAT dysfunction, which suggests that UCP3 might contribute to muscle energy expendi ture under some circumstances. 58 Muscle is thought to be the major site of facultative thermogenesis in adult humans; nevertheless, identification of significant BAT in the neck and clavicle region of adults that can be acti vated upon cold exposure suggests that this tissue has a previously unappreciated role in energy expenditure. [59] [60] [61] Human BAT seems to have a molecular signature similar to white adipose tissue with increased UCP1 expression, also termed 'beige' adipose tissue. 62 The identification of a musclederived circulating factor, irisin, that increases UCP1 levels in white adipose tissue and converts it to beige, suggests that muscle also has important indirect roles in the regulation of energy expenditure.
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T 3 -dependent glucose homeostasis Thyroid status regulates glucose homeostasis, with both thyrotoxicosis and hypothyroidism being associated with insulin resistance. 64 In patients with thyrotoxico sis and experimental animal models of thyrotoxicosis, increased hepatic gluconeogenesis along with a reduced insulin halflife contribute to hyperglycaemia, and the increased circulating free fatty acids and enhanced fatty acid uptake in muscle can further add to insulin resist ance. 55, 64, 65 Moreover, decreased insulinmediated glucose uptake in muscle has been observed in animal models of hypothyroidism. 1, 64 Muscle is one of the major tissues involved in glucose uptake, and, as mentioned above, the expression of GLUT4 is T 3 dependent. So, decreased GLUT4 expres sion has been hypothesized to contribute to lower glucose uptake in patients with hypothyroidism. 34 In addition, GLUT4 translocation to the surface of the cell is an in sulindependent event, and further studies have indi cated that normal muscle responsiveness to insulin requires local DIO2mediated conversion of T 4 to T 3 . 22, 66 Pri mary DIO2deficient myotube cultures have a blunted increase in the downstream target of insulin, phosphoryl ated AKT, whereas DIO2 activity is upregulated by the insu lin sensitizer pioglitazone in myotubes, suggesting that other insulindependent events, such as GLUT4 trans location, are also compromised in DIO2deficient myo tubes. 22 Studies showing that mice with a targeted deletion of the Dio2 gene (Dio2 -/-mice) are insulinresistant further confirm an important role for DIO2 in insulin action. 67 As mentioned previously, in humans, skeletal muscle is a site of major insulininduced glucose uptake. A common polymorphism in the human DIO2 gene results in a Thr92Ala substitution in the DIO2 enzyme. 68 About 19% of the population is homozygous for this allele. 69 This amino acid change does not affect a crucial catalytic region of the DIO2 protein, nor is the threonine residue conserved among species. However, homozygosity for this allele has been associated with a lower than normal glucose disposal rate in a group of 972 women with obesity, as well as with an increased homeostatic model assessment (HOMA) index, indicating increased insulin resistance. 68, 69 Interestingly, DIO2 activity was found to be significantly reduced in specimens of rectus abdominis muscle, sternocleidomastoid muscle and thyroid tissue from individuals who are homozygous for the DIO2 Thr92Ala polymorphism, as compared with hetero zygous individuals or with individuals lacking this poly morphism, although no differences were observed at the DIO2 mRNA level. 69 Comparisons between the wildtype threoninecontaining DIO2 and the alanine containing DIO2 variant showed no kinetic differences after tran sient expression in vitro. 69 To explain these results, the researchers proposed that the DIO2 Thr92Ala poly morphic allele is in linkage disequilibrium with another nearby gene that affects DIO2 function, or that this poly morphism might reduce DIO2 protein stability or mRNA translation. Strikingly, this polymorphism has also been associated with reduced bone density and osteo arthritis. 70 How ever, it did not correlate with the efficiency of levo thyroxine to suppress TSH in patients with hypo thyroidism. 71 More studies are required to identify the mechanism for these intriguing congruent associations of the DIO2 Thr92Ala polymorphism with abnormal glucose homeostasis and skeletal dis orders. However, these patient data, taken in context with the findings that insulin action is impaired in a DIO2deficient myo blast cell culture model and that Dio2 -/-mice are insulin resistant, strongly suggest that the local T 3 generated from T 4 by DIO2 in muscle plays a significant part in insulin action and glucose homeostasis.
22,67
T 3 -dependent skeletal muscle repair Skeletal muscle is a stable tissue with terminally post mitotic myonuclei that normally do not divide. None theless, mammalian muscles exhibit the capacity for extensive regeneration in response to injury. 72 Muscle repair is a function of satellite cells, which, when acti vated, can proliferate and supply new myofibres, as well as reconstitute the satellite cell pool for later rounds of regeneration. 73, 74 Regeneration is a highly orchestrated sequence of events that involves four sequential phases: first, a degenerative phase characterized by an inflamma tory response; second, the activation and proliferation of satellite cells; third, the differentiation and fusion of myoblasts; and, finally, the growth and maturation of newly formed myofibres (Figure 1) . 72 These events require a strictly regulated crosstalk between myofibres and paracrine and autocrine regulatory factors. Defects in these processes are the leading cause of muscle loss in patients with various muscular dystrophies. By contrast, a reduction in the expression of growth factors that are powerful inhibitors of muscle differentiation leads to premature differentiation of myoblasts and early fusion of myocyte precursor cells to form multinucleated myotubes. 75 Differentiation is intimately coupled to the cell cycle, and transcription of MRFs starts only when m yoblasts are arrested in the G1-G0 phase.
MYOD1 is the master transcriptional regulator of myogenesis, and its expression is sufficient for the In addition, T 3 signalling is involved in the upregulation of the myogenic regulatory factor family member myogenin in immature myotubes and some isoforms of the myosin heavy chain in mature myotubes, thereby affecting muscle function.
transdifferentiation of mesenchymallike cells to muscle cells. As mentioned above, MYOD1 transcription is directly controlled by T 3 . 38 Thus, thyroid hormone signal ling can control multiple events within the myogenic process through the direct and indirect regulation of the expression of an array of musclespecific genes (Figure 1 ). DIO2 expression is elevated not only in neonatal mouse muscle, but also during myoblast or myocyte precursor cell (MPC) differentiation. Loss of DIO2, either through proteasomal degradation or through genetic deletion, impairs MPC differentiation, as it prevents upregula tion of MYOD1 and the downstream myogenic factors. 19 The differentiation defects of DIO2deficient MPCs are coupled with an increase in their proliferative poten tial. Indeed, DIO2null muscles contain an increased number of satellite cells, which suggests that a reduction in the levels of intracellularly activated T 3 enhances the proliferative capacity of the MPCs in vivo. 19 Strikingly, a similar phenotype has been described in satellite cells from Myod1 -/-mice.
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DIO2 has been demonstrated to be a direct target of FOXO3, a forkhead transcription factor that is a down stream target of the PI3K-AKT signalling pathway. 19, 77 In skeletal muscle, FOXO proteins contribute to several cellular processes, such as myocyte fusion and regula tion of myocyte metabolism, 78, 79 and are key players in both atrophy and autophagy. 80, 81 Furthermore, FOXO3 has been shown to cooperate with PAX3 and PAX7 in driving MYOD1 expression, 82 and Foxo3 -/-mice have defects in muscle regeneration as a result of reduced MYOD1 expression. 82 These studies provide compelling evidence for a functional link between DIO2 induction via FOXO3 and myogenic differentiation.
In addition, our preliminary data indicate that the expression of DIO3 is specifically induced in proliferat ing MPCs and suppressed in differentiated MPCs. 83 Sequential expression of DIO3 followed by DIO2 in acti vated satellite cells could balance the different thyroid hormone requirements during the cell lineage progres sion with DIO3mediated low intracellular T 3 allowing for the expansion of the satellite cell pool, whereas increases in DIO2 expression and activity facilitate MPC differen tiation (Figure 2 ). These findings provide novel insights into the role of deiodinases in the linear progression of the myogenic programme. In addition, they open new hope for the use of hormonal regulation as a tool to manipu late the physiology of muscle stem cells, modulating their expansion and differentiation.
Thyroid hormones in muscle pathology
The term muscular dystrophy collectively describes a group of genetic diseases characterized by progressive muscle weakness owing to defective muscle function. Defective muscle function leads to premature exhaustion of the skeletal muscle stem cell pool. Duchenne muscu lar dystrophy (DMD) is a progressive disorder caused by deficiency of dystrophin, which is a crucial component of the cytoskeleton. 84, 85 Various animal models have been developed for studying muscle dystrophy, including a DMD mouse model. Dmd mdx mice lack dystrophin, and this defect triggers repeated cycles of muscle degenera tion and regeneration, causing a progressive reduction in the satellite cell population. 86 Alterations in thyroid hormone signalling can exacerbate the dystrophic pheno type of Dmd mdx mice by affecting cellcycle control and proliferation-differentiation balance in satellite cells. 87, 88 In particular, hypothyroidism exacerbated the phenotype of Dmd mdx mice by prolonging the replication phase of satellite cells and delaying the fusion of MPC precur sors into myotubes. 88 By contrast, thyro toxicosis pro moted the transition from proliferation toward fusion in regenerating muscles in both Dmd mdx and control mice, thus demonstrating that excess T 3 negatively affects the regeneration process by reducing MPC proliferation and inducing premature MPC fusion into myotubes. 89 As a result, both excesses and reductions in thyroid hormone signalling are detrimental for the correct progression of muscle regeneration and therefore amplify manifestations of the dystrophic phenotype.
These early observations have been confirmed by studies on the role of DIO2mediated control of thyroid hor mone signalling in satellite cell function. The regenera tion of cardiotoxininjured skeletal muscles of Dio2 -/-mice was markedly delayed compared with injured muscles of wildtype mice, and this delay was accompanied by a failure to upregulate the major markers of terminal muscle differentiation. Moreover, Dio2 -/-muscles developed a distinct phenotype following injury that was character ized by the presence of small, centrally nucleated myo fibres within the damaged area. 19 The failure of satellite cells to differentiate into myotubes in the Dio2 -/-skeletal muscle has been associated with an increase in their pro liferative capacity as a result of the attenuation of thyroid hormone signalling. These alterations lead to the observed delay in muscle regeneration after injury in Dio2 -/-mice. Con sistently, a comparable delay has been observed in the regeneration of injured muscles from mice lacking FOXO3, which lies upstream of DIO2 induction. 19, 82 Impor tantly, these data indicate that normal levels of T 3 in the plasma of Dio2 -/-mice are not sufficient for proper MPC differentiation during the late phases of regenera tion. Consistent with its expression in proliferating MPCs and with its observed role in other models of injury repair (that is, nerve repair or liver regeneration), DIO3 is highly expressed in the early phases of muscle regeneration, 83 thus suggesting a common requirement for low T 3 activ ity in the initial waves of the regeneration process. Taken together, these results illustrate the importance of cell autonomous mechanisms for the temporal and muscle specific control of intracellular T 3 levels. As modulation of the local T 3 levels can profoundly affect MPC proliferation, deiodinases could potentially be used to manipulate intra cellular thyroid hormone signalling and improve the pro liferative or differentiative capacity of transplanted sa tellite cells for the treatment of muscular dystrophy.
Conclusions
Thyroid hormone is a key endocrine regulator that primar ily functions through binding to nuclear thyroid hormone receptors and imposing a signature of gene expression. Whereas the important role of thyroid hormone signal ling in muscle physiology has been recog nized for many years, the contribution of local modulation of thyroid metabolism by the deiodinases to muscle physiology is a novel area in this field. Deiodinase function influences not only the mature properties of different muscles but, importantly, also the properties of the stemcelllike satel lite cells. Early results suggest that there is a temporally restricted expression of DIO2, and probably DIO3, in satel lite cells during muscle cell differentiation and repair. The outcome of this regulation is mostly unknown, but a requirement for DIO2mediated local conversion of T 4 to T 3 in the target tissues is clearly emerging from the above mentioned studies. Future in vivo studies are required to clarify the kinetics and coordination of DIO2 with DIO3 activity in develop ing and regenerating muscles, as well as to define the role of other important components that regulate thyroid hormone supply, such as the thyroid hormone trans porters. On a more speculative note, given the major role of skeletal muscle tissue in determining basal metabolic rate, manipulation of deiodinase activity in skeletal muscle could be a potential avenue to enhance energy expenditure as a weight management strategy in individuals with obesity, as this approach could bypass the adverse systemic effects of an increase in circulating thyroid hormones.
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